Hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) are commonly
inherited heart conditions associated with a high risk of heart failure and sudden cardiac …

Continuous‐flow left ventricular assist devices (LVADs) have gained tremendous
acceptance for the treatment of end‐stage heart failure patients. Among different versions …

If VADs and ECMO are to become part of routine care, they need to demonstrate that they
are cost-effective. Otherwise, the time and money they consume would be better spent …

Background To examine key factors influencing chronic kidney disease (CKD) patients' total
expenditure and offer recommendations on how to reduce total cost of CKD care without …

Background: Fulminant myocarditis (FM) is rare but has an extremely poor prognosis.
Impella, a catheter-based heart pump, is a new therapeutic strategy, but reports regarding its …

Aims: Patients with obstructive hypertrophic cardiomyopathy (oHCM) experience significant
clinical burden which is associated with a high economic burden. Peak oxygen uptake …

Background Advanced heart failure (HF) can be treated conservatively or aggressively, with
left ventricular assist devices (LVADs) and heart transplant (HT) being the most aggressive …

Continuous flow left ventricular assist device (CF-LVAD) therapy has improved the survival
of patients with advanced heart failure. However, the readmission rate of CF-LVAD patients …

Few socioeconomic studies have so far reported on revascularization for stable ischemic
heart disease in Japan. This study aimed to validate the sensitivity of the health-related …

End-stage heart failure is a syndrome that occurs when the heart is unable to fully perform its
function. Due to the inability to pump enough blood to the body, various disorders …